Latest News and Press Releases

ASTRAZENECA AND TARGACEPT ANNOUNCE TOP-LINE RESULTS FROM PHASE IIb STUDY OF AZD3480 IN COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA AstraZeneca and Targacept, Inc. today announced top-line results from a...

ASTRAZENECA AND TARGACEPT ANNOUNCE TOP-LINE RESULTS FROM PHASE IIB STUDY OF AZD3480 IN ALZHEIMER'S DISEASE · Results inconclusive, as primary outcome measure not statistically significant for either...

Contents   General information 3 Report of the supervisory board 5 Report of the management board 6 Financial statements 13 Balance...

Astrazeneca provides update on RECENTIN™ Clinical development programme HORIZON Colorectal Cancer Programme Continues Into Phase III; BR24 Non-Small Cell Lung Cancer Trial Will Not...

Not for release, publication or distribution directly or indirectly in or into the United States, Canada, Australia or Japan AstraZeneca launches and prices a debut GBP 350 million sterling bond and...

AstraZeneca response to FDA and Health Canada communication regarding omeprazole and Nexium (esomeprazole) The FDA and Health Canada today issued public notifications on numerical differences in...

[NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT...

AstraZeneca förvärvar produktionsanläggning för biologiska läkemedel i Kanada AstraZeneca meddelar idag förvärvet av en produktionsanläggning för biologiska läkemedel i Montreal, Kanada från DSM...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS...